Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for auxiliary identification of flunarizine hydrochloride original research medicine prescription composition

A flunarizine hydrochloride and auxiliary identification technology, which is applied in the field of medicine, can solve the problems of analysis, unfavorable original drugs, and increased difficulty in the development of generic drugs, etc., and achieve the effect of easy implementation and simple operation

Active Publication Date: 2022-07-01
北京阳光诺和药物研究股份有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the existing mass spectrometry, high performance liquid and other detection methods can only understand the composition and content of some excipients in the prescription of the original research drug, and cannot comprehensively and effectively analyze the composition of the prescription of the original research drug, which is not conducive to the comprehensive analysis of the original research drug. The development of generic drugs increases the difficulty

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for auxiliary identification of flunarizine hydrochloride original research medicine prescription composition
  • Method for auxiliary identification of flunarizine hydrochloride original research medicine prescription composition
  • Method for auxiliary identification of flunarizine hydrochloride original research medicine prescription composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0050] Flunarizine hydrochloride 170830 and 170820 used in the following examples are self-made products of our company;

[0051] The original research drug of flunarizine hydrochloride is the product of Xi'an Janssen Pharmaceutical Co., Ltd.

[0052] The instrument used was a HF-ExR610 Raman spectrometer.

[0053] batch number 170830 170820 Flunarizine hydrochloride 5.9 5.9 lactose 122.7 132.7 corn starch 20 10 talcum powder 9 9 silica 0.4 0.4 Magnesium stearate 2 2 total 160 160

[0054] The raw and auxiliary materials in the table are directly mixed, and then filled in the 4# red-gray capsule shell.

[0055] Example

[0056] 1. Sample direct test

[0057] After connecting the instrument, start the test and preheat for 0.5h.

[0058] For powder samples, take out a small amount of powder with a spatula and place it on a clean sample table, gently flatten it with a clean glass slide, focus the laser on the samp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for auxiliary identification of flunarizine hydrochloride original research medicine prescription composition. Whether the sample is the flunarizine hydrochloride original research medicine or not is judged by measuring the Raman spectrum information of the sample, operation is easy, and implementation is easy.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a method for assisting in identifying the composition of the original research drug prescription of flunarizine hydrochloride. Background technique [0002] Flunarizine hydrochloride is a calcium channel blocker, which can prevent cell damage caused by intracellular pathological calcium overload caused by ischemia and other reasons. It is suitable for cerebral arteriosclerosis, cerebral thrombosis, cerebral embolism, cerebral circulation disorder caused by hypertension, cerebral hemorrhage, cerebral circulation disorder caused by arachnoid, cerebral hemorrhage, etc. [0003] Flunarizine hydrochloride capsules were developed in 1968 by Johnson & Johnson Pharmaceuticals in the United States, and are only available in some countries in Europe, Asia and South America. They were first listed in 1977 under the trade name Sibelium. Because the original drug was launched relatively e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N21/65
CPCG01N21/65
Inventor 谌宗永刘宇晶罗桓白靳飞童元峰
Owner 北京阳光诺和药物研究股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products